US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

EssilorLuxottica

146.05

+2.111.47%

Volume:118.54K

Turnover:17.25M

Market Cap:133.07B

PE:54.09

High:146.41

Open:144.26

Low:144.23

Close:143.94

Loading ...

Overview Company News Filings

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2025

EssilorLuxottica: 2024 Universal Registration Document filed

Veteran Investor Touts Meta (META) and Oracle (ORCL)

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

Essilorluxottica (ESLOF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and ...

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

EssilorLuxottica Expected to Post Higher Revenue, Profit -- Earnings Preview

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

EssilorLuxottica upgraded to Buy from Hold at Jefferies

EssilorLuxottica acquires the Canadian med-tech start-up Cellview

AM Best Affirms Credit Ratings of EyeMed Insurance Company

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ESLOY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLOY\",,,,,undefined,":{"symbol":"ESLOY","market":"US","secType":"STK","nameCN":"EssilorLuxottica","latestPrice":146.05,"timestamp":1742846400000,"preClose":143.94,"halted":0,"volume":118544,"delay":15,"changeRate":0.014659,"change":2.11,"floatShares":577155969,"shares":911144148,"eps":2.699994,"lyrEps":2.823372,"pbRate":3.05,"amount":17247160.19560001,"amplitude":0.015145,"volumeRatio":5.910885925291765,"dividePrice":2.137483,"prevYearClose":120.67,"fiveDayClose":144.5,"twentyDayClose":150.05},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLOY\",,,,,undefined,":{"symbol":"ESLOY","floatShares":577155969,"roa":"3.49%","roe":"6.24%","lyrEps":2.823372,"volumeRatio":5.910885925291765,"shares":911144148,"dividePrice":2.137483,"high":146.41,"amplitude":0.015145,"preClose":143.94,"low":144.23,"week52Low":103.41,"pbRate":"3.05","psRate":"4.64","week52High":155.46,"institutionHeld":0,"latestPrice":146.05,"eps":2.699994,"divideRate":0.014635,"volume":118544,"delay":15,"ttmEps":2.699994,"open":144.2599,"prevYearClose":120.67,"prevWeekClose":143.94,"prevMonthClose":148.24,"prevQuarterClose":120.67,"fiveDayClose":144.5,"twentyDayClose":150.05,"sixtyDayClose":121.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLOY\",params:#limit:5,,,undefined,":[{"date":"2024-07-25","symbol":"ESLOY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721894400000,"name":null,"time":"","dateTimestamp":1721880000000,"actualEps":null},{"date":"2024-05-03","symbol":"ESLOY","amount":2.110682,"announcedDate":"2024-04-24","type":"dividend","market":"US","newRecordDate":"2024-05-06","defaultRemindTime":1714743000000,"name":"EssilorLuxottica","recordDate":"2024-06-18","payableDate":"2024-05-06","currency":"USD","dateTimestamp":1714708800000,"payDate":"2024-06-18"},{"market":"US","date":"2024-02-14","symbol":"ESLOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-07-25","symbol":"ESLOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690257600000,"reportTimeType":"","actualEps":null},{"date":"2023-05-22","symbol":"ESLOY","amount":1.770524,"announcedDate":"2023-05-10","type":"dividend","market":"US","newRecordDate":"2023-05-23","defaultRemindTime":1684762200000,"name":"EssilorLuxottica","recordDate":"2023-06-28","payableDate":"2023-05-23","currency":"USD","dateTimestamp":1684728000000,"payDate":"2023-06-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLOY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-14","recordDate":"2015-05-18","paymentDate":"2015-06-11","value":0.426282,"currency":"USD"},{"executeDate":"2016-05-10","recordDate":"2016-05-12","paymentDate":"2016-06-29","value":0.482375,"currency":"USD"},{"executeDate":"2019-05-24","recordDate":"2019-05-28","paymentDate":"2019-06-13","value":0.911459,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-13","value":0.539557,"currency":"USD"},{"executeDate":"2021-06-04","recordDate":"2021-06-07","paymentDate":"2021-07-06","value":0.503352,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLOY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLOY\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518722045","title":"EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518722045","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518722045?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:00","pubTimestamp":1741712400,"startTime":"0","endTime":"0","summary":"Paris, France  – As of February 28, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws1.1EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-disclosure-share-capital-voting-170000700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2361044949.HKD","LU1823568750.SGD","BK4581","LU0354030511.USD","LU0251132253.USD","SG9999000418.SGD","LU1791710582.SGD","LU1116320901.HKD","LU0265550359.USD","LU0965508806.USD","SG9999014906.USD","LU1814569148.SGD","LU1035775433.USD","LU2242649171.HKD","LU1974910355.USD","LU0354030438.USD","LU1691799644.USD","LU0061474960.USD","LU0942090050.USD","LU1043141396.HKD","ESLOY","LU0256863811.USD","LU1046421795.USD","LU2125154778.USD","LU2764263203.CNY","LU0426417589.USD","LU0029864427.USD","IE00B19Z9505.USD","LU1267930573.SGD","ESLOF","SGXZ81514606.USD","LU2720916845.USD","LU0672654240.SGD","GB00B4LPDJ14.GBP","LU0640476718.USD","IE00BQXX3C00.GBP","LU1804176565.USD","IE00B19Z8W00.USD","LU0823421416.USD","LU0965509101.SGD","LU0069063385.USD","LU1236620834.HKD","LU1917777945.USD","LU1934455863.HKD","LU0868494617.USD","LU0708995401.HKD","LU1815333072.USD","LU1642822529.SGD","LU2023251221.USD","LU0957791311.USD"],"gpt_icon":1},{"id":"2518083212","title":"EssilorLuxottica: 2024 Universal Registration Document filed","url":"https://stock-news.laohu8.com/highlight/detail?id=2518083212","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518083212?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:00","pubTimestamp":1741626000,"startTime":"0","endTime":"0","summary":"Paris, France  – EssilorLuxottica announces the availability of its 2024 Universal Registration Document, in accordance with applicable regulation. The French version of this document, prepared in ESEF format , was filed with theAutorité des Marchés Financiers on March 10, 2025 under the reference D.25-0081.The Universal Registration Document includes, in particular, the Annual Financial Report, with:. the Management Report and the Vigilance Plan, in compliance with articles L.225-100 and L.225-102-1 respectively of the French Commercial Code, as well as the Report on Corporate Governance as per article L.225-37 of the French Commercial Code and the Sustainability Report as per article L.233-28-4 of the French Commercial Code;a statement by the person responsible for the Universal Registration Document;the Statutory Auditors’ Reports on the parent Company and on the Group Consolidated Financial Statements, as well as the Report on the Certification of Sustainability Information; and. T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-2024-universal-registration-document-170000090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","UVV","ESLOY","ESLOF","BK4202","BK4075"],"gpt_icon":0},{"id":"2517452952","title":"Veteran Investor Touts Meta (META) and Oracle (ORCL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452952","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517452952?lang=en_us&edition=fundamental","pubTime":"2025-03-08 03:09","pubTimestamp":1741374541,"startTime":"0","endTime":"0","summary":"In the tech sector, investors should buy Meta  and Oracle , Seaport Securities' Ted Weisberg, the firm's founder and president, told Schwab TV today. Meta's valuation is relatively low, \"and it's still a big growth stock. At some point, it will be OK, although they don't ring a bell and tell us\" when that will be, Weisberg said.And although tech names in general are currently struggling, \"at some point they'll be OK because that is still at the end of the day where the growth is and that's where the earnings are,\" he said. As a result, he does not recommend that investors sell their tech stocks.Despite the uncertainty caused by political developments in Washington, a number of sectors are performing well, said Weisberg. Among large pharmaceutical names, which have struggled for the last two years, Bristol Myers  recently reached new highs, and Pfizer , which has had its problems for a long time, is beginning to perk up, he reported.Among European stocks, Weisberg touted Nestle  and Fra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/veteran-investor-touts-meta-meta-190901832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORCL","LU2456880835.USD","LU0109391861.USD","LU2237957811.SGD","LU1551013342.USD","LU2242646821.SGD","META","IE0002270589.USD","LU1093756325.SGD","LU2404859667.USD","LU2326559502.SGD","LU2430703251.USD","BK4538","LU2404859741.USD","BK4524","LU0203201768.USD","SG9999015978.USD","LU1914381329.SGD","LU1861559042.SGD","IE00BK4W5M84.HKD","BMY","LU0237698245.USD","ESLOY","LU0308772762.SGD","LU0353189763.USD","LU2463028550.USD","NSRGY","LU0354030511.USD","IE00BBT3K403.USD","LU0211331839.USD","LU0072462426.USD","LU2065171311.SGD","LU1069344957.HKD","BK4533","LU2505996509.AUD","LU1697837992.HKD","SG9999002232.USD","LU0149725797.USD","LU1429558221.USD","LU0215105999.USD","SG9999003800.SGD","LU0719512351.SGD","03165","LU0082616367.USD","IE00BSNM7G36.USD","LU0256863902.USD","LU0306806265.USD","LU1718418525.SGD","LU1989764664.SGD"],"gpt_icon":1},{"id":"2511520995","title":"EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511520995","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511520995?lang=en_us&edition=fundamental","pubTime":"2025-02-14 01:00","pubTimestamp":1739466000,"startTime":"0","endTime":"0","summary":"Paris, France  – As of January 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws1.1EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-disclosure-share-capital-voting-170000127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0354030438.USD","LU1035775433.USD","LU1670628061.USD","LU0889565833.HKD","LU1815333072.USD","LU0061474960.USD","LU1435385759.SGD","IE00B19Z8W00.USD","IE00BKVL7J92.USD","LU1988902786.USD","LU2360032135.SGD","LU0289961442.SGD","IE00BZ1G4Q59.USD","LU0215105999.USD","LU0957791311.USD","ESLOF","LU2764262908.HKD","LU1974910355.USD","LU0170899867.USD","LU2023251221.USD","LU0545562505.USD","BK4581","LU1633808545.USD","LU1623119135.USD","LU0289941410.SGD","LU1934455863.HKD","LU0157215616.USD","BK4535","BK4202","BK4588","LU2028103732.USD","LU2242649171.HKD","V","LU0965509101.SGD","LU2089283258.USD","LU2264538146.SGD","GB00B4LPDJ14.GBP","BK4198","LU1316542783.SGD","LU1366333091.USD","LU2237438978.USD","LU1121112475.USD","LU0097036916.USD","LU2764263039.SGD","LU0234570918.USD","ESLOY","LU0708994859.HKD","IE00BQXX3C00.GBP","LU0127658192.USD","LU0256863902.USD","LU0868494708.USD"],"gpt_icon":0},{"id":"2511548483","title":"EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2511548483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511548483?lang=en_us&edition=fundamental","pubTime":"2025-02-13 19:05","pubTimestamp":1739444700,"startTime":"0","endTime":"0","summary":"1105 GMT - EssilorLuxottica looks set to benefit from innovation in technological products, Bryan Garnier analyst Cedric Rossi writes in a note. The Franco-Italian eyewear group booked fourth-quarter sales of 6.78 billion euros, 9.2% higher on year at constant currency, helped by the success of its tech products. Ray-Ban Meta wearables, which incorporate an AI assistant and cameras, reached 2 million units sold since their launch in 2023, with a strong acceleration in 2024. The analyst expects escalating sales and profit contributions from technological products across lenses, smart eyewear, audiology and medtech categories. \"This new wave of technology is just beginning,\" the analyst says. Shares rise 5.7% to 291.60 euros. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ESLOY","BK4202"],"gpt_icon":0},{"id":"2511102215","title":"EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2511102215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511102215?lang=en_us&edition=fundamental","pubTime":"2025-02-13 18:54","pubTimestamp":1739444040,"startTime":"0","endTime":"0","summary":"1054 GMT - EssilorLuxottica's confirmation of midterm margin guidance casts doubts, UBS analysts write in a research note. The Ray-Ban maker maintained expectations of mid-single-digit annual revenue growth through 2026 at constant exchange rates. It also targets an adjusted operating margin between 19% and 20% by the end of that period. This implies a margin expansion of nearly 100 basis points a year, which could be challenging due to the ongoing investments, UBS says. Shares are up 5.6% at 291.40 euros. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLOY","BK4202","BK4198"],"gpt_icon":0},{"id":"2511515518","title":"EssilorLuxottica's Sales Are Better Than Expected -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2511515518","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511515518?lang=en_us&edition=fundamental","pubTime":"2025-02-13 16:41","pubTimestamp":1739436060,"startTime":"0","endTime":"0","summary":"0840 GMT - EssilorLuxottica posted better-than-expected sales for the fourth quarter, Jefferies analysts write in a note to clients. The Franco-Italian eyewear group behind reported 6.78 billion euros in sales, up 9.2% on year at constant currency. That is above Visible Alpha consensus of 6.5% growth, the analysts point out. Sales were lifted by a recovery in North America, where revenue grew 7.8% at constant currency to 3.15 billion euros. The company said its North American business had its best quarter of the year. EssilorLuxottica shares trade 2.4% higher at 282.70 euros. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLOY"],"gpt_icon":1},{"id":"2511591116","title":"Essilorluxottica (ESLOF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511591116","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511591116?lang=en_us&edition=fundamental","pubTime":"2025-02-13 15:14","pubTimestamp":1739430877,"startTime":"0","endTime":"0","summary":"Revenue Growth: Fourth quarter revenue up 9%, full year revenue up 6%.Stellest Performance: 60% growth in China for the full year.Adjusted Operating Margin: Increased by 50 basis points.Ray-Ban Meta Sales: Over 2 million units sold since September 2023.Regional Revenue Growth: Latin America and Asia Pacific just below 10%, EMEA approximately 8%, North America 3% for full year 2024.Gross Margin: Expanded by 30 basis points at constant currency.Free Cash Flow: EUR2.4 billion for the full year 2024.GuruFocus has detected 6 Warning Sign with IFCZF.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Essilorluxottica  reported a 9% revenue growth in Q4 and 6% for the full year 2024, driven by strong organic growth and new wearable categories.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-eslof-q4-2024-earnings-071437357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESLOF","ESLOY"],"gpt_icon":0},{"id":"2511583274","title":"Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2511583274","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511583274?lang=en_us&edition=fundamental","pubTime":"2025-02-13 02:20","pubTimestamp":1739384400,"startTime":"0","endTime":"0","summary":"Ray-Ban maker EssilorLuxottica posted higher sales for the fourth quarter fueled by strong growth in North America and China.The Franco-Italian eyewear group reported quarterly revenue of 6.78 billion euros , up 9.2% on year at constant currency. Analysts had forecast 6.68 billion euros in revenue, according to a Visible Alpha consensus.In North America, which accounts for more than 40% of EssilorLuxottica's sales, fourth-quarter revenue rose 7.8% at constant currency to 3.15 billion euros. The company said its North American business had recorded its best quarter of the year, adding that the consolidation of Supreme also contributed to sales growth.Meanwhile, the group said revenue in China jumped roughly 50% in the quarter, with strong demand for its Stellest myopia lenses. Sales in the Asia-Pacific region climbed 14% at constant currency to 864 million euros.Meanwhile, the company is also ramping up its focus on medical technology. Earlier this week, it acquired the ophthalmology di","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MKR.USD.CC","ESLOY","MKR.USD.HKCC"],"gpt_icon":1},{"id":"2511075723","title":"EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start","url":"https://stock-news.laohu8.com/highlight/detail?id=2511075723","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511075723?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:00","pubTimestamp":1739379600,"startTime":"0","endTime":"0","summary":"Smartglasses as a new driver, Nuance off to a promising start. Group revenue at constant exchange rates1 +9.2% in Q4 and +6.0% in the FY. North America accelerating in Q4, with SGH positive; sound EMEA driven by both PS and DTC. Ray-Ban Meta at 2 million units sold since the launch, with strong acceleration in 2024. Nuance Audio cleared, starting off in the US OTC and Europe. Adjusted2 operating margin at 17.0% at constant exchange rates1, advancing by 50bps versus 2023. Strong free cash flow5 at Euro 2.4 billion in the FY. SBTi validated greenhouse gas emission reduction targets 2030 for scopes 1, 2 and 3. Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “We celebrate another year of remarkable achievements, with our fourth consecutive year of top line growth on track with our targets, including a strong acceleration in Q4, with all regions and businesses contributing to our momentum, followed by new record high in the Group’s profit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-q4-fy-2024-results-170000415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESLOY","NUAN","ESLOF"],"gpt_icon":1},{"id":"2510333481","title":"EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333481","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510333481?lang=en_us&edition=fundamental","pubTime":"2025-02-12 00:30","pubTimestamp":1739291400,"startTime":"0","endTime":"0","summary":"1630 GMT - EssilorLuxottica's earnings are accelerating on a steadily-growing optical market and a potential expansion of its smart glasses portfolio, Jefferies analysts say in a note. The Ray-Ban maker extended a partnership with Meta Platforms to develop smart-eyewear products with a new long-term agreement. Given Meta's ambitions in wearables, a broadened partnership or stakeholding seems possible, the analysts say. Jefferies analysts expect a third generation of smart glasses to be potentially ready for consumers in time for the 2025 holiday-shopping season. The broker upgrades its rating on the stock to buy from hold. Shares are up 1.8% at 277.20 euros. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLOY","BK4202","BK4198"],"gpt_icon":0},{"id":"2510333870","title":"EssilorLuxottica Expected to Post Higher Revenue, Profit -- Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510333870?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:50","pubTimestamp":1739285400,"startTime":"0","endTime":"0","summary":"Ray-Ban maker EssilorLuxottica is scheduled to report results for 2024 on Wednesday. Here is what you need to know.SALES FORECAST: The European eyecare giant is expected to report revenue of 26.43 billion euros  for 2024 as a whole, according to a poll of 15 analysts' estimates compiled by Visible Alpha. In 2023, the company booked revenue of 25.40 billion euros. For the fourth quarter alone, analysts expect revenue of 6.68 billion euros, up from 6.25 billion euros in the prior-year period.NET PROFIT FORECAST: Analysts project full-year net profit of 2.50 billion euros, according to the same consensus, up from 2.29 billion euros in 2023.--RAY-BAN META: EssilorLuxottica extended a partnership with Meta Platforms to develop smart eyewear products with a new long-term agreement. The glasses maker is focused on improving product features, including battery and new designs, but could also launch new brands in its smart-glasses push, Jefferies analysts said in a research note. Given Meta's a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLOY","POST"],"gpt_icon":0},{"id":"2510280176","title":"EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2510280176","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510280176?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:58","pubTimestamp":1739271480,"startTime":"0","endTime":"0","summary":"1058 GMT - EssilorLuxottica's purchase of Cellview Imaging marks the second acquisition in ophthalmology diagnostics for the European eyecare giant as it pushes into this and other subcategories, RBC Capital Markets' Piral Dadhania says in a note. The Ray-Ban maker said it is buying Canadian startup Cellview, which offers diagnostics via retinal imaging, for an undisclosed sum. The deal follows EssilorLuxottica's July acquisition of Heidelberg Engineering, another ophthalmology diagnostics company, and strengthens its offering, RBC says. EssilorLuxottica is pursuing a structural expansion into selective ophthalmology subcategories, with a move into diagnostics already in progress and potentially in cataracts and contact lenses down the line, the analyst says. Shares rise 1.1%. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ESLOY","BK4202"],"gpt_icon":0},{"id":"2510803788","title":"EssilorLuxottica upgraded to Buy from Hold at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510803788?lang=en_us&edition=fundamental","pubTime":"2025-02-11 17:34","pubTimestamp":1739266448,"startTime":"0","endTime":"0","summary":"Jefferies upgraded EssilorLuxottica (ESLOY) to Buy from Hold with a price target of EUR 310, up from EUR 195. The company is a “structural share ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/essilorluxottica-upgraded-to-buy-from-hold-at-jefferies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/essilorluxottica-upgraded-to-buy-from-hold-at-jefferies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4202","ESLOY"],"gpt_icon":0},{"id":"2510878489","title":"EssilorLuxottica acquires the Canadian med-tech start-up Cellview","url":"https://stock-news.laohu8.com/highlight/detail?id=2510878489","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510878489?lang=en_us&edition=fundamental","pubTime":"2025-02-11 15:00","pubTimestamp":1739257200,"startTime":"0","endTime":"0","summary":"The company’s ultra-widefield proprietary technology allows for fast and easy high-quality images, providing a comprehensive view of the retina. Francesco Milleri, Chairman and CEO and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “We are happy to welcome Cellview’s team to EssilorLuxottica and to work together to accelerate our strategy in vision health. By integrating another pioneering company with strong expertise in R&D and world-class imaging solutions, we will provide a comprehensive portfolio of innovative technologies to the ophthalmic care community to better address the growing need of vision health and the early diagnosis of retinal pathologies. While our products and services remain accessible to all industry players – as a pillar of EssilorLuxottica’s open business model – we continue to elevate market standards, in full alignment with our journey into the med-tech space”.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/essilorluxottica-acquires-canadian-med-tech-070000328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EssilorLuxottica acquires the Canadian med-tech start-up Cellview","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","ESLOF","ESLOY","BK4202"],"gpt_icon":0},{"id":"2509469271","title":"AM Best Affirms Credit Ratings of EyeMed Insurance Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2509469271","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509469271?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:24","pubTimestamp":1738686240,"startTime":"0","endTime":"0","summary":"OLDWICK, N.J., February 04, 2025----AM Best has affirmed the Financial Strength Rating of A  and the Long-Term Issuer Credit Rating of \"a\"  of EyeMed Insurance Company  , a subsidiary of EssilorLuxottica [EL: PA]. The outlook of these Credit Ratings  is stable.The ratings reflect EIC’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management , as well as enhancement received from its ultimate parent organization, EssilorLuxottica.This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/am-best-affirms-credit-ratings-162400980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESLOF","AM","ESLOY"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":1,"totalSize":47}]}}